
VACHU
Voyager Acquisition Corp Unit
$10.700+0.000 (0.000%)
실시간 가격
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$0.000
고가
$0.000
저가
$0.000
거래량
0.00M
기업 기본 정보
거래 통계
관련 뉴스
GlobeNewswire
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
VERAXA's Novel BiTAC Platform has the Potential to Deliver Multiple Next-Generation Solid Tumor Cancer Therapies, Including Novel Antibody-Drug Conjugate ("ADC") and Bispecific T-cell Engager ("TCE")
더 보기